p16和p53可以作为头部和部状细胞癌的预后标记

Yue Wang1, Fang Wang2, Shuhan Wang3

  • 1Department of Oral and Maxillofacial Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, China; Department of stomatology, ZiBo Central Hospital, ZiBo, Shandong, China; School of Stomatology, Binzhou Medical University, Yantai, China.

PubMed
概括

p16和p53表达水平是预测头部和部状细胞癌 (HNSCC) 预后的关键指标. 使用这些因素验证的生存模型可靠地预测临床实践中的患者结果.